Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VII

7GC & Co. Holdings Inc. (VII) Stock Price, News & Analysis

About 7GC & Co. Holdings Inc. Stock (NASDAQ:VII)

Advanced Chart

Key Stats

Today's Range
$0.17
$0.26
50-Day Range
$10.96
$10.96
52-Week Range
$9.00
$16.57
Volume
797,148 shs
Average Volume
39,241 shs
Market Capitalization
$1.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

7GC & Co. Holdings Inc. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business opportunities in the field of technology. 7GC & Co. Holdings Inc. was incorporated in 2020 and is based in San Francisco, California.

Receive VII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 7GC & Co. Holdings Inc. and its competitors with MarketBeat's FREE daily newsletter.

VII Stock News Headlines

Elon Musk is all in on these robots …
Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang said, "The ChatGPT moment for robotics is right around the corner." In fact, I believe these robots could impact 65 million Americans lives — this year. And one stock — currently priced around $7 — could be the biggest winner.
G-7 Holdings Reports Sales Growth Amid Profit Challenges
See More Headlines

VII Stock Analysis - Frequently Asked Questions

7GC & Co. Holdings Inc. (NASDAQ:VII) announced its quarterly earnings data on Monday, May, 14th. The company reported ($0.08) EPS for the quarter. The firm had revenue of $7.32 million for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that 7GC & Co. Holdings Inc. investors own include Canopy Growth (CGC), Allena Pharmaceuticals (ALNA), Biocept (BIOC), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF) and AcelRx Pharmaceuticals (ACRX).

Company Calendar

Last Earnings
5/14/2018
Today
5/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:VII
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$9.44 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.03 per share
Price / Cash Flow
6.68
Book Value
($2.34) per share
Price / Book
-0.09

Miscellaneous

Free Float
4,259,000
Market Cap
$1.87 million
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:VII) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners